Validation and functional follow-up of cervical cancer risk variants at the HLA locus.
Eisenblätter R, Seifert F, Schürmann P, Beckhaus T, Hanel P, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Müller F, Hein A, Stuebs F, Koch M, Ruebner M, Beckmann MW, Fasching PA, Luyten A, Häfner N, Hillemanns P, Dörk T, Ramachandran D.
Eisenblätter R, et al. Among authors: hillemanns p.
HLA. 2024 Aug;104(2):e15597. doi: 10.1111/tan.15597.
HLA. 2024.
PMID: 39101335